ChemicalBook > CAS DataBase List > Ganitumab

Ganitumab

Product Name
Ganitumab
CAS No.
905703-97-1
Chemical Name
Ganitumab
Synonyms
AMG 479;Ganitumab;Ganitumab 4.92mg/ml;Ganitumab (anti-IGF1R);Research Grade Ganitumab;Research Grade Ganitumab (DHC29902)
CBNumber
CB38080757
Formula Weight
0
MOL File
Mol file
More
Less

Ganitumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Ganitumab Chemical Properties,Usage,Production

Uses

Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer[1].

in vivo

Ganitumab (AMG 479; 1 mg/dose; i.p; Na?ve and tumor-bearing mice) inhibits IGF1-induced activation of mIGF1R in murine lungs[1].
Ganitumab (300 μg/dose; i.p.; female athymic nude mice) reduces peripheral blood neutrophils[1].
Ganitumab (300 μg/dose; i.p.; male athymic nude mice) causes impaired glucose tolerance in male mice and increases serum levels of mGH, mIGF1 and mIGFBP3[1].

Animal Model:Na?ve and tumor-bearing mice[1]
Dosage:1 mg/dose
Administration:Intraperitoneal injection
Result:Inhibited the IGF1-induced activation of mIGF1R and inhibited 80% tumor growth.
Animal Model:Male athymic nude mice[1]
Dosage:300 μg/dose
Administration:Intraperitoneal injection, twice per week for a total of five doses
Result:Had significantly higher serum glucose levels than hIgG1-pretreated mice.
Increased serum levels of mIGF1, mIGFPB3 and mGH.
Animal Model:Female athymic nude mice[1]
Dosage:300 μg/dose
Administration:Intraperitoneal injection, twice per week for a total of five doses
Result:Reduced the number of peripheral neutrophils up to 50% compared with hIgG1 controls.

References

[1] Moody G, et, al. IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice. J Endocrinol. 2014 Mar 17;221(1):145-55. DOI:10.1530/JOE-13-0306

Ganitumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ganitumab Suppliers

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
doncunbiosci@gmail.com
Country
China
ProdList
544
Advantage
58
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58

905703-97-1, GanitumabRelated Search:


  • Ganitumab
  • Research Grade Ganitumab (DHC29902)
  • AMG 479
  • Research Grade Ganitumab
  • Ganitumab (anti-IGF1R)
  • Ganitumab 4.92mg/ml
  • 905703-97-1